Pruritus therapeutics market to reach $16.88 billion by 2030 at 6.6% CAGR, driven by rise in the incidence of dermatological disorders.
Read MoreZoledronic acid market to reach $4.33 billion by 2030 at 4.4% CAGR, driven by rising bone disorders and increasing number of cancer cases worldwide.
Read MoreZinc cold lozenges market to reach $1.82 billion by 2030 at 7.0% CAGR, driven by growing incidence of respiratory infections and expanding e commerce healthcare platforms.
Read MoreYellow fever vaccine market to reach $5.88 billion by 2030 at 4.3% CAGR, driven by increasing international travel to endemic regions requiring mandatory immunization.
Read MoreXerostomia therapeutics market to reach $2.79 billion by 2030 at 4.3% CAGR, driven by rising prevalence of chronic diseases and growing geriatric population.
Read MoreWound care biologics market to reach $3.19 billion by 2030 at 9.2% CAGR, driven by high prevalence of diabetes increasing demand for advanced wound healing solutions.
Read MoreWomen’s health and beauty supplements market to reach $157.26 billion by 2030 at 11.7% CAGR, driven by rising disposable income supporting investment in personalized wellness products.
Read MoreWnt signaling pathway inhibitor market to reach $4.93 billion by 2030 at 9.7% CAGR, driven by rising demand for targeted therapies and increasing prevalence of chronic diseases.
Read MoreWilson’s disease drugs market to reach $0.9 billion by 2030 at 6.4% CAGR, driven by growing incidence of genetic disorders requiring long term copper regulation therapies.
Read MoreWhey protein isolate market to reach $9.01 billion by 2030 at 8.6% CAGR, driven by increasing health and fitness awareness and adoption of high protein dietary patterns.
Read More